3:05 PM
 | 
Feb 06, 2018
 |  BioCentury  |  Finance

Stepping up in Europe

How EdRIP plans to deploy its €345 million life sciences fund

After closing one of Europe’s largest ever life sciences VC funds, Edmond de Rothschild Investment Partners now has the firepower to follow portfolio companies longer and put more capital to work in a wider variety of investment opportunities than previous funds allowed.

EdRIP closed BioDiscovery 5 fund at €345 million ($428 million), topping an initial target of €250 million ($310.1 million).

“We are very happy with this size because it propels us into the top league here in Europe and is also of comparable size to U.S. VCs,” the firm’s Olivier...

Read the full 439 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >